Form 4: Director Betsy Holden Receives Dentsply Sirona RSU Grant

Dentsply Sirona director Betsy D. Holden was granted 22,822 restricted stock units as part of annual equity compensation.

Summary

• Director Betsy D. Holden acquired 22,822 restricted stock units (RSUs) of Dentsply Sirona (XRAY) common stock.
• The transaction occurred on June 3, 2026.
• The RSUs were granted at a price of $0, representing standard equity-based compensation for board members.
• Following this transaction, the director's total beneficial ownership increased to 77,441.799 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine regulatory filing that reflects standard corporate governance and director compensation practices.

Positives

• Alignment of director interests with shareholders through increased equity ownership.
• Standardized compensation structure utilizing restricted stock units.

Negatives

• None identified; this is a routine disclosure of director compensation.

Risks

• None identified; this is a standard regulatory filing regarding insider holdings.

Future Outlook

The RSUs are scheduled to vest in full one year from the date of the grant, on June 3, 2027.

Industry Context

StockSavvy.ai notes that this filing is a routine administrative disclosure common in the medical device industry, where board members are typically compensated with equity to ensure long-term alignment with corporate performance.

Comparison to Industry Standards

• The grant of equity to non-employee directors is consistent with standard corporate governance practices among S&P 500 and mid-cap medical technology companies.
• The one-year vesting schedule is a standard retention mechanism for board-level equity compensation.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard equity grant to a director.

Next Steps

• Vesting of the 22,822 RSUs on June 3, 2027.

Key Dates

Keywords

Dentsply Sirona, XRAY, Form 4, Insider Trading, Director Compensation, Restricted Stock Units